Company: WELNF
Filing Date: 2025-11-12
Form Type: DEFM14A
Source: 0001104659-25-109577
Chunk: 516

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-12
Form: DEFM14A
Chunk 516
---
 unsettled the amount demanded by the dissenting shareholder.

In the event of a court proceeding, the court will determine all costs of the proceeding, including the reasonable compensation and expenses of appraisers appointed by the court, but not including fees and expenses of attorneys and experts for the respective parties. The court will assess these costs against Btab, except that the court may assess these costs against all or some of the dissenters in amounts the court finds equitable to the extent the court finds the dissenters acted arbitrarily or not in good faith in demanding payment under the dissenters’ provisions. The court may also assess the fees and expenses of attorneys and experts for the respective parties in amounts the court finds equitable: (i) against Btab and in favor of any or all dissenters if the court finds Btab did not substantially comply with the dissenters’ provisions; or (ii) against Btab or a dissenter in favor of any other party if the court finds that the party against whom fees and expenses are assessed acted arbitrarily or not in good faith with respect to the rights provided by the dissenters’ provisions. If the court finds that the services of attorneys for any dissenter were of substantial benefit to other dissenters similarly situated and that the fees for those services should not be assessed against Btab, the court may award these attorneys reasonable fees to be paid out of the amounts awarded the dissenters who were benefited.

Btab shareholders should be aware that cash paid to dissenting shareholders in satisfaction of the fair value of their shares of Btab stock will result in the recognition of any gain or loss realized for U.S. federal income tax purposes.

Failure by a Btab shareholder to follow the steps required by the GBCC for perfecting dissenters’ rights may result in the loss of such rights. In view of the complexity of these provisions and the requirement that they be strictly complied with, if you hold shares of Btab stock and are considering dissenting from the approval of the Btab merger proposal and exercising your dissenters’ rights under the GBCC, you should consult your legal advisors.

<div align='center'>294</div>

TABLE OF CONTENTS

### FUTURE SHAREHOLDER PROPOSALS AND NOMINATIONS
For any proposal to be considered for inclusion in Pubco’s proxy statement and form of proxy for submission to the stockholders at Pubco’s 2026 annual meeting of shareholders, assuming consummation of the Business Combination, it must be submitted in writing and comply with the requirements of Rule 14a-8 of